Skip to main content
    W

    West Pharmaceutical Services Inc (WST)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $383.25
    +8.60 (+2.30%)

    Market Cap: $26.37B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +13.75%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.20
    Range$2.16 - $2.23
    14 analysts
    EPS Revisions
    9
    0
    7d
    9
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$2.13+3.3%
    60d ago$2.19+0.3%
    30d ago$2.19+0.3%
    7d ago$2.19+0.1%
    Current$2.20
    Revenue Consensus
    $827M
    Range$821M - $836M
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.01
    Range$2.88 - $3.10
    17 analysts
    Revenue Consensus
    $929M
    Range$913M - $957M
    16 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.01---
    Sep 26EST
    		-$2.20---
    Jun 26
    Reported Jul 23
    		$2.37$2.08+13.94%Beat+28.8%
    Mar 26
    Reported Apr 23
    		$2.13$1.68+26.79%Beat+46.9%
    Dec 25
    Reported Feb 12
    		$2.04$1.83+11.48%Beat+12.1%
    Sep 25
    Reported Oct 23
    		$1.96$1.71+14.62%Beat+5.9%
    Jun 25
    Reported Jul 24
    		$1.84$1.54+19.48%Beat+21.1%
    Mar 25
    Reported Apr 24
    		$1.45$1.26+15.08%Beat-7.1%
    Dec 24
    Reported Feb 13
    		$1.82$1.71+6.43%Beat-0.5%
    Sep 24
    Reported Oct 24
    		$1.85$1.49+24.16%Beat-14.4%
    Jun 24
    Reported Jul 25
    		$1.52$1.73-12.14%Miss-28.0%
    Mar 24
    Reported Apr 25
    		$1.56$1.29+20.93%Beat-21.2%
    Dec 23
    Reported Feb 15
    		$1.83$1.78+2.81%Beat+3.4%
    Sep 23
    Reported Oct 26
    		$2.16$1.86+16.13%Beat+6.4%
    Jun 23
    Reported Jul 27
    		$2.11$1.93+9.33%Beat-14.6%
    Mar 23
    Reported Apr 27
    		$1.98$1.67+18.56%Beat-13.9%
    Dec 22
    Reported Feb 16
    		$1.77$1.38+28.26%Beat-13.2%
    Sep 22
    Reported Oct 27
    		$2.03$2.12-4.25%Miss-1.5%
    Jun 22
    Reported Jul 28
    		$2.47$2.21+11.76%Beat+0.4%
    Mar 22
    Reported Apr 28
    		$2.30$2.12+8.49%Beat+12.2%
    Dec 21
    Reported Feb 17
    		$2.04$1.92+6.25%Beat+52.2%
    Sep 21
    Reported Oct 28
    		$2.06$1.80+14.44%Beat+79.1%
    Jun 21
    Reported Jul 29
    		$2.46$1.74+41.38%Beat+96.8%
    Mar 21
    Reported Apr 29
    		$2.05$1.43+43.36%Beat+103.0%
    Dec 20
    Reported Feb 18
    		$1.34$1.13+18.58%Beat+63.4%
    Sep 20
    Reported Oct 22
    		$1.15$0.99+16.16%Beat+45.6%
    Jun 20
    Reported Jul 23
    		$1.25$0.92+35.87%Beat+40.4%
    Mar 20
    Reported Apr 23
    		$1.01$0.82+23.17%Beat+36.5%
    Dec 19
    Reported Feb 13
    		$0.82$0.72+13.89%Beat+12.3%
    Sep 19
    Reported Oct 24
    		$0.79$0.71+11.27%Beat+3.9%
    Jun 19
    Reported Jul 25
    		$0.89$0.72+23.61%Beat+27.1%
    Mar 19
    Reported Apr 25
    		$0.74$0.66+12.12%Beat+19.4%
    Dec 18
    Reported Feb 14
    		$0.73$0.72+1.39%Beat+14.1%
    Sep 18
    Reported Oct 25
    		$0.76$0.70+8.57%Beat+13.4%
    Jun 18
    Reported Jul 26
    		$0.70$0.67+4.48%Beat+6.1%
    Mar 18
    Reported Apr 26
    		$0.62$0.64-3.13%Miss+3.3%
    Dec 17
    Reported Feb 15
    		$0.64$0.63+1.59%Beat+18.5%
    Sep 17
    Reported Oct 26
    		$0.67$0.53+26.42%Beat-
    Jun 17
    Reported Jul 27
    		$0.66$0.65+1.54%Beat-
    Mar 17
    Reported Apr 27
    		$0.60$0.56+7.14%Beat-
    Dec 16
    Reported Feb 16
    		$0.54$0.56-3.57%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.23%
    Forward Annual Dividend$0.88
    Payout Ratio11.03%
    FrequencyQuarterly
    Pay MonthsFeb, May, Aug, Nov

    Growth

    3Y CAGR+5.20%
    5Y CAGR+5.51%
    WST dividend history and ex-dividend datesRun WST in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio45.09EV/EBITDA31.25x
    Price/FCF62.11xFCF Yield1.61%
    Profitability
    Profit Margin17.00%Operating Margin22.50%
    ROE19.10%ROIC16.85%
    Financial Health
    Debt/Equity0.07xInterest Coverage150.98x
    Current Ratio2.82xQuick Ratio2.12x
    Trading Statistics
    Beta1.13Avg Volume578.44K
    52-Week High$385.7552-Week Low$223.52

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$370.75
    SMA 20$370.53
    SMA 50$357.44
    SMA 200$306.56
    EMA 10$372.13
    EMA 20$368.52
    EMA 50$359.42
    EMA 200$319.05

    MACD

    Line: 4.90Signal: 4.72Hist: 0.18

    ADX

    ADX: 34.7+DI: 30.0-DI: 11.1

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$359.49

    Bollinger Bands

    Upper Band$382.04
    Lower Band$359.02
    %B Position621%(Upper)
    Band Width1.05

    RSI (14-Day)

    Neutral
    65.1

    Momentum Oscillators

    Stoch %K72.8
    Stoch %D54.7
    Williams %R-4.6
    ROC (10d)5.0%
    Momentum18.24
    CCI (20d)176.5
    MFI (14d)63.9

    Volatility Measures

    ATR (14d)$8.93(2.3%)
    StdDev (20d)5.75
    Hist Vol22.9%(Moderate)

    Volume Flow

    VWAP$381.25
    OBV7.2M
    AD Line-9.1M
    CMF (20d)-0.006

    Volume Metrics

    Avg Vol (20d)581.5K
    Vol Ratio0.7x
    VWMA (20d)$370.11

    Pivot Points

    R3$385.50
    R2$382.36
    R1$378.50
    Pivot Point$375.36
    S1$371.50
    S2$368.36
    S3$364.50

    Advanced Oscillators

    TSI16.74
    Ultimate Osc49.2
    KST50.02

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$872.30M$844.90M$805.00M$804.60M$766.50M$698.00M$748.80M$746.90M$702.10M$695.40M$732.00M$747.40M
    Cost of Revenue$543.10M$548.50M$501.10M$510.30M$492.60M$466.10M$475.20M$482.20M$472.10M$465.20M$453.80M$459.10M
    Gross Profit$329.20M$296.40M$303.90M$294.30M$273.90M$231.90M$273.60M$264.70M$230.00M$230.20M$278.20M$288.30M
    Operating Expenses$150.10M$119.30M$147.30M$126.70M$120.20M$124.90M$114.00M$103.40M$103.80M$107.40M$117.30M$111.00M
    R&D$19.70M$15.80M$21.80M$17.10M$19.10M$16.30M$18.50M$15.50M$17.50M$17.60M$18.40M$16.40M
    SG&A$117.60M$99.50M$107.00M$102.70M$95.90M$88.00M$85.30M$83.50M$83.00M$86.70M$90.00M$89.00M
    Operating Income$179.10M$177.10M$156.60M$167.60M$153.70M$107.00M$159.60M$161.30M$126.20M$122.80M$160.90M$177.30M
    Interest Income$3.80M$5.10M$5.10M$4.70M$3.60M$4.10M$4.80M$4.60M$4.00M$6.20M$9.40M$8.80M
    Interest Expense$2.60M$1.90M$-200,000$200,000$100,000$400,000$-800,000$700,000$1.50M$1.60M$1.20M$2.90M
    Income Before Tax$180.10M$180.10M$161.50M$171.90M$157.00M$110.50M$164.90M$164.50M$128.70M$127.40M$168.20M$187.00M
    Income Tax Expense$32.20M$44.70M$33.30M$34.00M$30.20M$24.10M$36.80M$32.40M$21.90M$16.40M$34.50M$29.40M
    Net Income$154.00M$138.80M$132.10M$140.00M$131.80M$89.80M$130.10M$136.00M$111.30M$115.30M$137.00M$161.30M
    EBITDA$225.10M$222.10M$203.20M$210.40M$194.90M$146.80M$200.00M$200.80M$165.10M$158.40M$196.80M$216.80M
    EBIT$178.90M$176.90M$156.20M$167.40M$153.50M$106.80M$159.30M$160.60M$126.20M$122.80M$160.90M$181.10M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    The Biggest Healthcare Disconnect In Decades - And The Stocks I’m Watching

    Healthcare has hit a 26-year relative low, but weakness alone does not make the sector a buy. AI-led capital flows, patent cliffs, IRA pricing pressure, and GLP-1 disruption explain much of the selloff. I prefer selective exposure: picks-and-shovels, AI-driven platforms...

    Leo Nelissen
    •
    5/25/26
    •
    459
    Healthcare Stocks, Dividend Investing, value investing
    Also mentions:
    TMOWSTLLYISRGPFE

    News

    How Investors May Respond To West (WST) Raised Guidance

    West Pharmaceutical Services (WST) recently raised its full-year revenue and earnings guidance, driven by strong demand for high-value pharmaceutical packaging components...

    Simply Wall Street•10/16/26•Bullish

    West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com

    West Pharmaceutical Services (WST) stock has reached a new 52-week high of $386.08, reflecting a 42.22% increase over the past year. Despite its strong performance and a "GREAT" financial health score...

    Investing.com UK•10/16/26•Bullish

    West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains

    West Pharmaceutical Services Inc. (WST) stock increased by 2.23% on Thursday, closing at $383.02. Despite this gain and a positive overall market performance with the S&P 500 and Dow Jones Industrial Average also rising...

    MarketWatch•10/15/26•Somewhat-Bearish

    West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?

    West Pharmaceutical Services (WST) stock has rallied 36.1% year-to-date due to strong demand for high-value pharmaceutical packaging components, robust earnings...

    TradingView•10/15/26•Bullish

    West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?

    West Pharmaceutical Services (WST) shares have rallied 36.1% year-to-date, significantly outperforming its industry due to strong demand for high-value pharmaceutical packaging components, robust earnings...

    TradingView•10/15/26•Bullish

    WST Valuation and Fair Value

    P/E
    45.1x
    Forward P/E
    37.0x
    EV/EBITDA
    31.3x
    P/FCF
    62.1x
    PEG
    3.4x
    P/B
    9.1x
    See GNG's fair value

    WST Profitability: Margins, ROIC and FCF

    Gross margin
    36.8%
    Operating margin
    22.5%
    Net margin
    17.0%
    ROIC
    16.9%
    ROE
    19.1%
    FCF margin
    13.1%
    FCF yield
    1.6%

    WST Competitors

    CompanyTicker
    Zoetis IncZTS
    Laboratory Corporation of America HoldingsLH
    GE HealthCare Technologies Inc.GEHC
    Quest Diagnostics IncorporatedDGX
    DexCom IncDXCM
    Roivant Sciences LtdROIV
    Mettler-Toledo International IncMTD
    Koninklijke Philips NV ADRPHG

    Sector: Healthcare

    WST Analyst Ratings

    Consensus
    Buy
    Analysts
    17
    Strong Buy
    4
    Buy
    12
    Hold
    1
    Sell
    0
    Strong Sell
    0

    WST Bull Case vs Bear Case

    Bull case

    • WST earns a 16.9% return on invested capital.
    • WST beat EPS estimates in 100.0% of its last 8 reported quarters.
    • WST grew quarterly revenue 13.8% year over year.

    Bear case

    • WST trades at 45.1x trailing earnings.

    WST Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    16.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.20
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    9 up, 0 down

    WST Dividend

    Forward yield
    0.2%
    Payout ratio
    11.0%
    3Y DPS growth
    5.2%
    5Y DPS growth
    5.5%
    Pay months
    Feb, May, Aug, Nov
    WST dividend history

    Frequently Asked Questions About WST

    What is WST's current dividend yield?

    West Pharmaceutical Services Inc (WST) has a forward dividend yield of 0.23%.

    Does WST pay dividends?

    Yes, West Pharmaceutical Services Inc pays dividends with a forward dividend yield of 0.23%.

    What is WST's P/E ratio?

    West Pharmaceutical Services Inc has a price-to-earnings (P/E) ratio of 45.09.

    What is WST's market cap?

    West Pharmaceutical Services Inc (WST) has a market capitalization of $26.37B with a current stock price of $383.25.

    Related stocks

    Sector: Healthcare

    All stocks starting with W

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In